You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 54 No. 1, January 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  BOOK REVIEW
 This Article
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Autoimmune Neurologic Disease

by Michael P. Pender and Pamela A. McCombe, 377 pp, $100, New York, NY, Cambridge University Press, 1995.

Steven R. Schwid, MD, Reviewer
Rochester, NY

Arch Neurol. 1997;54(1):19.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The authors of this book have attempted to "provide a comprehensive overview of the immunological aspects of autoimmune neurological disease." Beginning with chapters on antigen recognition, self-nonself discrimination, and general aspects of neuroimmunology, the authors introduce the principal components of the immune system, effector and regulatory functions, as well as the cells and structures (eg, the blood-brain barrier) of the central and peripheral nervous system that are involved in the autoimmune processes to be discussed.

Experimental allergic encephalomyelitis (EAE) is then introduced as a model for multiple sclerosis and autoimmune neurological diseases in general. Methods of induction, pathogenesis, and pathological and immunological findings are discussed in detail. One shortcoming here is the limited discussion of cytokines that have been the focus of many recent advances. This is particularly apparent in the section on therapeutic interventions for EAE, where T-cell vaccinations and anti—T-cell receptor treatments are discussed . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.